ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 1171

$923K Total Retail Price of All Prescriptions

Rank: 50 out of 1171

602 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 13,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 1,040 979 1 1
LEVOTHYROXINE SODIUM 685 632 2 4
METFORMIN HCL 464 437 3 7
LISINOPRIL 459 395 4 3
AMLODIPINE BESYLATE 431 423 5 2
FUROSEMIDE 382 351 6 6
HYDROCHLOROTHIAZIDE 342 314 7 9
CITALOPRAM HBR 340 294 8 22
ATORVASTATIN CALCIUM 327 299 9 10
OMEPRAZOLE 316 271 10 5
CARVEDILOL 276 263 11 20
WARFARIN SODIUM 273 241 12 12
METOPROLOL SUCCINATE 250 240 13 17
GLIMEPIRIDE 221 216 14 34
METOPROLOL TARTRATE 218 208 15 11
HYDROCODONE-ACETAMINOPHEN 206 182 S3 16 8
SERTRALINE HCL 199 178 17 23
ZOLPIDEM TARTRATE 185 137 18 21
PANTOPRAZOLE SODIUM 183 174 19 29
NEXIUM 176 157 20 25
LOSARTAN POTASSIUM 168 161 21 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 156 22 26
DONEPEZIL HCL 131 121 23 24
CLOPIDOGREL 128 113 24 35
SPIRIVA 126 102 25 57
RAMIPRIL 120 110 26 85
JANUVIA 114 109 27 66
POTASSIUM CHLORIDE 112 99 28 19
DIOVAN 105 105 29 32
GABAPENTIN 102 84 30 16
KLOR-CON M20 100 100 31 41
CELEBREX 99 99 32 100
PLAVIX 91 84 33 55
TRAZODONE HCL 90 73 34 37
LEVOFLOXACIN 88 80 35 105
PAROXETINE HCL 85 72 36 62
CRESTOR 83 81 37 27
ADVAIR DISKUS 80 66 38 51
RANITIDINE HCL 78 73 39 38
ATENOLOL 77 76 40 15
TAMSULOSIN HCL 74 73 41 28
SINGULAIR 71 60 42 78
PRAVASTATIN SODIUM 71 68 42 13
PROAIR HFA 66 38 44 49
QUINAPRIL HCL 65 65 45 156
DIOVAN HCT 63 61 46 65
HUMALOG 61 60 47 132
CYMBALTA 59 42 48 64
PEN NEEDLE 58 47 49 122
FLUTICASONE PROPIONATE 57 42 50 30
SPIRONOLACTONE 56 45 51 53
TRIAMTERENE-HCTZ 56 56 51 58
PROPRANOLOL HCL 55 55 53 134
ISOSORBIDE MONONITRATE ER 54 49 54 44
MIRTAZAPINE 53 51 55 50
TRAMADOL HCL 51 43 56 18
DIVALPROEX SODIUM 51 27 56 106
LANSOPRAZOLE 50 48 58 150
FINASTERIDE 50 50 58 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.